Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Keryx Biopharmaceuticals buy klostergang

Start price
€4.74
07.11.17 / 50%
Target price
€7.22
04.11.21
Performance (%)
0.00%
End price
-
17.06.21
Summary
This prediction ended on 17.06.21 with a price of -. klostergang's BUY prediction for Keryx Biopharmaceuticals closed unchanged from the start price. klostergang has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Keryx Biopharmaceuticals - - - -
iShares Core DAX® 1.280% 1.320% 13.605% 15.782%
iShares Nasdaq 100 -2.457% -5.192% 25.941% 38.434%
iShares Nikkei 225® -2.006% -1.389% 8.973% 6.570%
iShares S&P 500 -0.662% -1.884% 23.684% 39.611%

Comments by klostergang for this prediction

In the thread Keryx Biopharmaceuticals diskutieren
Prediction Buy
Perf. (%) 0.00%
Target price 7.216
Change
Ends at 04.11.21

klostergang stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu

klostergang stimmt am 07.11.2017 der fundamentalen Bewertung mit dem Ergebnis unterbewertet zu.